Five Catalysts Behind Morgan Stanley’s Bullish Outlook On Senior Housing Assets
Morgan Stanley continues to highlight senior housing as a resilient offering within diversified real estate markets. Analyst Ronald Kamdem underscores how demographic shifts have bolstered healthcare real‑estate investment trusts delivering steady dividends. These equity owners have exceeded the broader index over the past year, posting a 31.3 percent return contrasted with the S&P 500’s 20.7 percent advance.
The aging cohort presents compelling demand; projections place adults aged 80 and older at roughly 23 million by 2025—near double the seven‑year mark. Current occupancy nears 90 percent, ahead of new build pipelines and indicating heightened attractiveness. Kamdem marks the inflection point where stronger supply pressures give way to upper‑tier operational leverage.
“Senior housing can move from a recovery trade into a scenario defined by operative and pricing leverage,” Kamdem explains. “Record low inventory growth alongside an accelerating 80+ profile suggest occupancy milestones beyond 95 percent soon.”
The research also explores growth avenues via M&A activity. Kamdom anticipates Welltower committing $15.4 billion in 2026 and $5 billion in 2027, American Healthcare earmarking $1.9 billion and $800 million respectively, and Ventas allocating $4.5‑$2 billion for the same horizons.
A structural mix shift away from traditional sectors benefits senior housing REITs. Welltower still accounts for about 70 percent of the benchmark, American Healthcare sits near 80 percent, while Ventas trails at approximately 55 percent. Concentrating risk toward higher‑yield prospects amplifies upside potential.
Deleveraging offers a crucial safety net. Each firm has curtailed balance‑sheet leverage, granting REITs a cost‑of‑capital edge relative to private alternatives. Strong earnings momentum and targeted equity raises further cement refinancing resilience.
Consistent executions round out the case. Welltower has delivered 15 straight quarters of 20 percent same‑store NOI expansion. Ventas posted ten‑percent growth within the comparable window. American Healthcare, entering markets earlier, posted standout multifloric gains with combined‑shop NOI rising 23.8 percent in 2024 and 52.8 percent in 2025.
Also Read
- Zelenskyy Warns Airlines Amid Escalating Drone Attacks Target Russian Airspace
- Oil Futures Jump as US-Iran Conflict Threatens Strait of Hormuz Energy Flows
- The Atlantic Brief: U.S. and European Perspectives on Nuclear Deterrence
- Beijing Tightens Information Control Amid Tibet Floods, Contrasting With Nepal’s Open Coverage
